Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, UK
Creon 10000 Capsules.
| Pharmaceutical Form |
|---|
|
Brown/clear capsules containing gastro-resistant granules. |
Each capsule contains:
Lipase 10,000 PhEur units.
Amylase 8,000 PhEur units.
Protease 600 PhEur units.
| Active Ingredient | Description | |
|---|---|---|
| Pancreatin |
Pancreatin when reaching the small intestine disintegrates (at pH>5.5) to release enzymes with lipolytic, amylolytic and proteolytic activity to ensure the digestion of fats, starches and proteins. The products of pancreatic digestion are then either absorbed directly, or following further hydrolysis by intestinal enzymes. |
| List of Excipients |
|---|
|
Granules: Macrogol 4000 Capsule shell: Gelatin |
HDPE container with tamper-evident PP cap. Containers hold 100, 250 or 300 capsules.
Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, UK
PL 46302/0028
01 January 2001
| Drug | Countries | |
|---|---|---|
| CREON | Australia, Brazil, Canada, Cyprus, Ecuador, Finland, France, Hong Kong, Ireland, Israel, Malta, Mexico, Netherlands, New Zealand, Singapore, Tunisia, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
